Tectonic Therapeutic | AVRO - Market Capitalization


Tectonic Therapeutic reported $280M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Celltrion KRW 1.81T 620B Jun/2026
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 2.46B 2.87B Nov/2026
Divis Laboratories Ltd INR 1.75T 167.78B Jun/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Kangmei Pharma CNY 16.59B 7.89B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
MacroGenics USD 151M 143M Nov/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 128.48M 74.94M Nov/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pfizer USD 172.71B 9.3B Nov/2026
Pharma Mar EUR 1.17B 85.18M Nov/2026
Qiagen NV USD 8.07B 197.36M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Sartorius EUR 17.42B 1.8B Sep/2026
Takeda JPY 9.26T 1.06T Sep/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026
Zz Pientze Pharmaceu CNY 76.62B 5.43B Nov/2026